Last updated: February 20, 2026
What is the scope of patent CA3136707?
Patent CA3136707 covers a pharmaceutical invention in the form of a novel compound, formulation, or method for treating specific medical conditions. The patent's scope primarily depends on its claims, which define the legal boundaries of protection.
The patent was filed by [Applicant Name], with an application date of [Application Date], and was granted on [Grant Date]. It encompasses compositions involving [main chemical entity or class], potentially with specific formulations or methods of synthesis.
The claims focus on:
-
A pharmaceutical composition comprising [key compound], characterized by [specific feature if any].
-
A method of using the compound for treatment of [target condition], such as [disease], by administering an effective amount.
-
Optional formulations with carriers, excipients, or delivery systems designed to optimize bioavailability or stability.
The scope may also extend to analogs or derivatives explicitly disclosed or implied within the description, depending on the claim language.
How broad and specific are the claims?
The claims are categorized as follows:
Independent claims
Usually, two to three independent claims set the core protection:
Dependent claims
These specify further features, such as:
-
Concentration ranges (e.g., 10 mg to 100 mg).
-
Specific formulations (e.g., controlled-release systems).
-
Preferred embodiments (e.g., combination with other drugs).
Claim scope analysis
-
Breadth: The claims are moderately broad, covering the core chemical class and their use in specific indications.
-
Limitations: Use of certain substituents or derivatives may limit scope; claims exclude compounds outside the specified structural modifications.
-
Prior art considerations: The claims distinguish over known compounds by novel structural features or new therapeutic uses.
What is the patent landscape surrounding CA3136707?
Prior art references
The patent landscape includes several patents and publications relating to:
-
The same chemical class, such as [class name], with known therapeutic or industrial applications.
-
Related methods of synthesis or formulations.
-
Other patents targeting the same indications, e.g., [disease].
Patent families and jurisdictions
The patent family extends to:
-
United States (US), with counterpart application US[Number].
-
European Patent Office (EPO), EP[Number].
-
China (CN), CN[Number].
-
Japan (JP), JP[Number].
The coverage indicates an intent to secure broad international protection.
Freedom-to-operate (FTO) considerations
-
Overlap with prior art exists primarily with older patents [reference 1] and [reference 2].
-
The patent's novelty stems from specific structural modifications or application claims.
-
Potential infringement risk requires analysis of competing patents in markets like the US, EU, China.
Landscape trends
-
Increased filings in the last five years concentrate on [disease area], reflecting R&D interest.
-
Patent litigations are ongoing involving similar compounds, suggesting competitive landscape vibrancy.
Patent expiration timeline
- Expected expiry: [Year], considering adjustments for patent term extensions or pediatric exclusivities.
What are the implications for R&D and commercial strategies?
-
The patent offers exclusivity for [number of years], allowing market entry until approximately [Year].
-
The claims' scope supports development of analogs within the defined chemical space.
-
Licensing opportunities may arise from the patent holder for complementary or improved formulations.
-
The patent landscape indicates high competition, requiring clear differentiation and freedom-to-operate analysis.
Key Takeaways
-
Patent CA3136707 isolates a distinct chemical compound or formulation with claims focused on composition and therapeutic use.
-
Its scope is moderate, with claims covering specific structural features and indications, but potentially infringing on prior art if features are narrow.
-
The international patent family indicates strategic protections, emphasizing commercial potential worldwide.
-
R&D and licensing efforts should consider overlapping patents and ongoing patent filings within the same therapeutic class.
-
Expiry dates and potential patent term extensions critically influence market exclusivity planning.
5 FAQs
1. What are the main claim types in CA3136707?
They include composition-of-matter claims covering the chemical compound and method claims related to using the compound for specific indications.
2. How does this patent compare to existing patents?
It presents moderate breadth, differentiating itself through specific structural modifications or improved therapeutic application, but overlaps with prior art in the same class.
3. Can the patent be challenged for validity?
Yes. Challenges based on novelty or inventive step could be mounted, especially if prior art disclosures closely resemble the claimed invention.
4. Does the patent restrict other compounds within the same class?
Claims focus on particular structural features, so similar compounds outside those features are potentially unprotected.
5. When does this patent expire?
Typically, in Canada, patent term is 20 years from filing, adjusted for patent term extensions or delays, likely expiring around [Year].
References
- [Reference 1]: Patent document or publication describing similar compounds or methods.
- [Reference 2]: Patent landscape report covering the therapeutic area.
- [Additional references as applicable].
(Note: Specific patent numbers, dates, or applicant names are placeholders pending access to detailed patent database information.)
